Profile picture

Doctor Sonia Eiras

Health Research Institute, Santiago de Compostela (Spain)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Adipose and non-adipose layers of epicardium: paracrine activity consequences on cardiomyocytes and modulation by semaglutide
Presentation
Adipose and non-adipose layers of epicardium: paracrine activity consequences on cardiomyocytes and modulation by semaglutide
Differential released proteins between epicardial and subcutaneous fat from patients with cardiovascular disease: role on its progression and semaglutide modulation
Presentation
Differential released proteins between epicardial and subcutaneous fat from patients with cardiovascular disease: role on its progression and semaglutide modulation
Semaglutide modulates pro-inflammatory neutrophil phenotype induced by supraphysiological levels of the adipokine FABP4 in patients with cardiovascular disease.
Presentation
Semaglutide modulates pro-inflammatory neutrophil phenotype induced by supraphysiological levels of the adipokine FABP4 in patients with cardiovascular disease.
Epicardial carbohydrate antigen 125 (CA-125) levels, associated with neutrophils activity in heart failure: No differences regarding sex
Presentation
Epicardial carbohydrate antigen 125 (CA-125) levels, associated with neutrophils activity in heart failure: No differences regarding sex
Semaglutide modulates adipogenic differentiation and extracellular acidification in epicardial (EAT) and subcutaneous (SAT) adipose tissue stromal cells from patients with cardiovascular disease.
Presentation
Semaglutide modulates adipogenic differentiation and extracellular acidification in epicardial (EAT) and subcutaneous (SAT) adipose tissue stromal cells from patients with cardiovascular disease.
Predicting post-operative atrial fibrillation after heart surgery: clinical profile and biomarkers
Presentation
Predicting post-operative atrial fibrillation after heart surgery: clinical profile and biomarkers
Semaglutide effects on human epicardial and subcutaneous fat released exosomes, aortic endothelial cells and neutrophils
Presentation
Semaglutide effects on human epicardial and subcutaneous fat released exosomes, aortic endothelial cells and neutrophils
MUC-16, tumour and congestive heart failure marker, is expressed on epicardial mesothelial cells and is inversely associated with epicardial fat genesis
Presentation
MUC-16, tumour and congestive heart failure marker, is expressed on epicardial mesothelial cells and is inversely associated with epicardial fat genesis

ESC 365 is supported by